{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2000-P-0133\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-2000-P-0133-0050", "FDA", "FDA-2000-P-0133", "Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease; Reopening of the Comment Period", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2011-08-11T04:00:00Z", 2011, 8, "2011-08-11T04:00:00Z", "2011-10-26T03:59:59Z", "2011-08-11T14:44:41Z", "2011-20406", 0, 0, "0900006480eddb33"], ["FDA-2000-P-0133-0047", "FDA", "FDA-2000-P-0133", "List of References 31-69 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2011-03-25T04:00:00Z", 2011, 3, null, null, "2011-03-25T21:03:47Z", null, 0, 0, "0900006480befe54"], ["FDA-2000-P-0133-0046", "FDA", "FDA-2000-P-0133", "Acknowledgement Letter to Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2013-07-27T23:48:11Z", null, 0, 0, "0900006480c0df46"], ["FDA-2000-P-0133-0045", "FDA", "FDA-2000-P-0133", "Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP) - Petition for Stay", "Other", "PSA-Petition for Stay", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2013-08-11T03:13:44Z", null, 0, 0, "0900006480c0ba3b"], ["FDA-2000-P-0133-0043", "FDA", "FDA-2000-P-0133", "Exhibit D - \"Kevin C. Maki, Ph.D. - Curriculum Vitae\" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T23:33:59Z", null, 0, 0, "0900006480c0111d"], ["FDA-2000-P-0133-0040", "FDA", "FDA-2000-P-0133", "Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition", "Other", "CP-Citizen Petition", "2011-03-04T05:00:00Z", 2011, 3, "2011-03-04T05:00:00Z", null, "2024-11-07T22:28:35Z", null, 1, 0, "0900006480bfae26"], ["FDA-2000-P-0133-0044", "FDA", "FDA-2000-P-0133", "Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-04T05:00:00Z", 2011, 3, "2011-03-04T05:00:00Z", null, "2013-07-27T23:46:13Z", null, 0, 0, "0900006480bfae28"], ["FDA-2000-P-0133-0041", "FDA", "FDA-2000-P-0133", "Exhibit A - \"Container and Carton Label for Nature Made\u00ae Cholestoff\u00ae\" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T23:33:56Z", null, 0, 0, "0900006480c0084b"], ["FDA-2000-P-0133-0042", "FDA", "FDA-2000-P-0133", "Exhibit C - \"Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)\" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2000-P-0133-0040", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T23:33:57Z", null, 0, 0, "0900006480c0084d"], ["FDA-2000-P-0133-0038", "FDA", "FDA-2000-P-0133", "Exhibit D - \"Kevin C. Maki, Ph.D. - Curriculum Vitae\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:23:58Z", null, 0, 0, "0900006480bfd1d7"], ["FDA-2000-P-0133-0035", "FDA", "FDA-2000-P-0133", "Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", null, "2013-08-11T01:40:09Z", null, 0, 0, "0900006480bfa3f2"], ["FDA-2000-P-0133-0037", "FDA", "FDA-2000-P-0133", "Exhibit C - \"Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:24:25Z", null, 0, 0, "0900006480bfa43b"], ["FDA-2000-P-0133-0039", "FDA", "FDA-2000-P-0133", "Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", null, "2013-08-11T01:40:09Z", null, 0, 0, "0900006480bfa423"], ["FDA-2000-P-0133-0036", "FDA", "FDA-2000-P-0133", "Exhibit A - \"Container and Carton Label for Nature Made\u00ae Cholestoff\u00ae\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2000-P-0133-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:24:48Z", null, 0, 0, "0900006480bfa428"], ["FDA-2000-P-0133-0028", "FDA", "FDA-2000-P-0133", "Reference - \"Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies\" - [Health Claim; Phytosterols and Risk of Coronary Heart Disease] re FDA-2000-P-0133-0025", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T21:01:53Z", null, 0, 0, "0900006480bf13be"], ["FDA-2000-P-0133-0029", "FDA", "FDA-2000-P-0133", "Attachment 4 - \"On Nutrition and Health Claims Made on Food\" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-FDA-2000-P-0133-0027", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:02:59Z", null, 0, 0, "0900006480bfad82"], ["FDA-2000-P-0133-0030", "FDA", "FDA-2000-P-0133", "Attachment 5 - \"On the Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk an to Children's Development and Health \" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2000-P-0133-0027", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:04:12Z", null, 0, 0, "0900006480bfad83"], ["FDA-2000-P-0133-0031", "FDA", "FDA-2000-P-0133", "Attachment 6 - \"Amending Regulation (EC) No. 983/2009 on the Authorisation and Refusal of Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk and to Children's Development and Health\" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2000-P-0133-0027", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:05:12Z", null, 0, 0, "0900006480bfad84"], ["FDA-2000-P-0133-0026", "FDA", "FDA-2000-P-0133", "Reference - \"Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies, February 14, 2003\" - [Extension of Enforcement Discretion: Health Claim, Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG-Background Material", "2011-02-18T05:00:00Z", 2011, 2, null, null, "2011-02-18T23:19:29Z", null, 0, 0, "0900006480bf251f"], ["FDA-2000-P-0133-0025", "FDA", "FDA-2000-P-0133", "Health Claim; Phytosterols and Risk of Coronary Heart Disease", "Proposed Rule", "NEC-Notice of Extension", "2011-02-18T05:00:00Z", 2011, 2, "2011-02-18T05:00:00Z", "2011-04-20T03:59:59Z", "2011-02-28T20:59:23Z", "2011-3678", 0, 0, "0900006480bf251c"], ["FDA-2000-P-0133-0023", "FDA", "FDA-2000-P-0133", "Venable LLP - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2011-02-15T05:00:00Z", 2011, 2, "2011-02-15T05:00:00Z", null, "2013-07-27T23:45:23Z", null, 0, 0, "0900006480befd94"], ["FDA-2000-P-0133-0022", "FDA", "FDA-2000-P-0133", "Venable, LLP - Request for Extension of Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2011-02-14T05:00:00Z", 2011, 2, "2010-12-08T05:00:00Z", "2011-02-12T04:59:59Z", "2013-07-27T23:44:52Z", null, 0, 0, "0900006480bec04f"], ["FDA-2000-P-0133-0019", "FDA", "FDA-2000-P-0133", "Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.) - Petition for Stay", "Other", "PSA-Petition for Stay", "2011-02-01T05:00:00Z", 2011, 2, "2011-02-01T05:00:00Z", null, "2013-08-11T01:39:31Z", null, 0, 0, "0900006480bd6ec6"], ["FDA-2000-P-0133-0020", "FDA", "FDA-2000-P-0133", "Acknowledgement Letter to Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.)", "Other", "ACK-Acknowledgement Letter", "2011-02-01T05:00:00Z", 2011, 2, "2011-02-01T05:00:00Z", null, "2013-07-27T23:43:59Z", null, 0, 0, "0900006480bd6f6b"], ["FDA-2000-P-0133-0018", "FDA", "FDA-2000-P-0133", "Acknowledgement Letter to Covington & Burling (Cargill Inc.)", "Other", "ACK-Acknowledgement Letter", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2013-07-27T23:42:02Z", null, 0, 0, "0900006480bc81d6"], ["FDA-2000-P-0133-0017", "FDA", "FDA-2000-P-0133", "Covington & Burling (Cargill Inc.) - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2024-11-12T04:58:05Z", null, 1, 0, "0900006480bc81d4"], ["FDA-2000-P-0133-0016", "FDA", "FDA-2000-P-0133", "Council for Responsible Nutrition - Letter", "Other", "LET-Letter", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2013-07-27T23:42:02Z", null, 0, 0, "0900006480bc81d2"]], "truncated": false, "filtered_table_rows_count": 27, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2000-P-0133", "p2": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-P-0133&posted_year=2011", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011", "results": [{"value": "Other", "label": "Other", "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=last_modified"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-P-0133&posted_year=2011&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1371.7342128511518, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}